iifl-logo-icon 1

Shree Ganesh Biotech India Ltd Share Price

1.21
(-3.20%)
Jul 18, 2024|03:44:00 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open1.25
  • Day's High1.26
  • 52 Wk High1.89
  • Prev. Close1.25
  • Day's Low1.13
  • 52 Wk Low0.7
  • Turnover (lac)23.59
  • P/E62.5
  • Face Value1
  • Book Value1.57
  • EPS0.02
  • Mkt. Cap (Cr.)48.23
  • Div. Yield0
No Records Found

Shree Ganesh Biotech India Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

1.25

Prev. Close

1.25

Turnover(Lac.)

23.59

Day's High

1.26

Day's Low

1.13

52 Week's High

1.89

52 Week's Low

0.7

Book Value

1.57

Face Value

1

Mkt Cap (₹ Cr.)

48.23

P/E

62.5

EPS

0.02

Divi. Yield

0

Shree Ganesh Biotech India Ltd Corporate Action

1 Sep 2023

12:00 AM

BookCloser

arrow

22 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

1 Sep 2023

12:00 AM

AGM

Announcement Date: 01 Sep, 2023

arrow

Shree Ganesh Biotech India Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Shree Ganesh Biotech India Ltd SHAREHOLDING SNAPSHOT

18 Jul, 2024|03:57 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 0.00%

Foreign: 0.00%

Indian: 0.00%

Non-Promoter- 1.43%

Institutions: 1.42%

Non-Institutions: 98.57%

Custodian: 0.00%

Share Price

Shree Ganesh Biotech India Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

39.86

19.93

19.93

19.93

Preference Capital

0

0

0

0

Reserves

22.49

40.39

37.86

37.54

Net Worth

62.35

60.32

57.79

57.47

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

17.21

2.47

7.85

8.53

yoy growth (%)

596.07

-68.52

-7.95

302.84

Raw materials

-16.32

-1.57

-3.36

-4.02

As % of sales

94.86

63.69

42.82

47.1

Employee costs

-0.07

-0.06

-0.09

-0.09

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

0.7

0.23

3.5

3.73

Depreciation

0

0

0

0

Tax paid

-0.11

0

0

0

Working capital

-2.04

3.52

1.27

6.3

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

596.07

-68.52

-7.95

302.84

Op profit growth

198.22

-93.21

-6.89

469.93

EBIT growth

199.31

-93.24

-6.91

504.15

Net profit growth

34.31

-93.26

-6.23

592.39

View Ratios

No Record found

Shree Ganesh Biotech India Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,579.25

124.153,78,914.98867.60.855,536.9998.75

Cipla Ltd

CIPLA

1,511.35

32.861,22,044.231,038.40.563,444.92346.41

Divis Laboratories Ltd

DIVISLAB

4,564.95

76.931,21,185.085310.662,259507.93

Zydus Lifesciences Ltd

ZYDUSLIFE

1,184.85

34.691,19,223.631,405.20.253,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,643.15

25.871,10,827.471,034.80.65,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Shree Ganesh Biotech India Ltd

Management

Register Office

Registrar Office

Independent Director

Sombir Singh

Independent Director

Chandni Solanki

Non Executive Director

Kishan Nityanand Naidu

Company Sec. & Compli. Officer

Namita Acharya

Independent Director

Harshadkumar Rathod

Chairman & Wholetime Director

Aman Patel

Non Executive Director

Amrutaben Solanki

Independent Director

Nimeshkumar Parmar

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Shree Ganesh Biotech India Ltd was incorporated on 2 September 1982 as a public limited company. The Company has got the Certificate of Commencement of Business on September 14, 1982 from the Registrar of Companies, West Bengal. The Company is presently engaged in the business of production, processing and marketing of high quality hybrid seeds for different crops like corn, sunflower, cotton, paddy, grain sorghum, etc.In 2010, pursuant to a Scheme of Amalgamation, Shree Ganesh Bio-Tech (India) Private Limited was merged with S.P. Commercial Co. Limited pursuant to the order of the Honble High at Calcutta dated February 15, 2010. The entire business of Shree Ganesh Bio-Tech (India) Private Limited consisting of trading and distribution of seeds were transferred to S.P. Commercial Co. Limited. Subsequently, Shree Ganesh Bio-Tech (India) Private Limited was dissolved pursuant to the said Scheme of Amalgamation and the name of the Company was changed to Shree Ganesh Bio-Tech (India) Limited. The name of the Company was changed to Shree Ganesh Bio-Tech (India) Limited and a fresh certificate of incorporation consequent up on the change of name dated March 7, 2011 was issued by the Registrar of Companies, West Bengal.
Read More

Company FAQs

What is the Shree Ganesh Biotech India Ltd share price today?

Down Arrow

The Shree Ganesh Biotech India Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹1.21 today.

What is the Market Cap of Shree Ganesh Biotech India Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Shree Ganesh Biotech India Ltd is ₹48.23 Cr. as of 18 Jul ‘24

What is the PE and PB ratio of Shree Ganesh Biotech India Ltd?

Down Arrow

The PE and PB ratios of Shree Ganesh Biotech India Ltd is 62.5 and 0.79 as of 18 Jul ‘24

What is the 52 Week High and Low of Shree Ganesh Biotech India Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Shree Ganesh Biotech India Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Shree Ganesh Biotech India Ltd is ₹0.7 and ₹1.89 as of 18 Jul ‘24

What is the CAGR of Shree Ganesh Biotech India Ltd?

Down Arrow

Shree Ganesh Biotech India Ltd's CAGR for 5 Years at -26.93%, 3 Years at -40.42%, 1 Year at 19.05%, 6 Month at -14.38%, 3 Month at 2.46% and 1 Month at 9.65%.

What is the shareholding pattern of Shree Ganesh Biotech India Ltd?

Down Arrow

The shareholding pattern of Shree Ganesh Biotech India Ltd is as follows:
Promoters - 0.00 %
Institutions - 2.17 %
Public - 97.83 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.